INSULIN PRICING LITIGATION Assigned to: Judge Brian R. Martinotti Referred to: Magistrate Judge Leda D. Wettre Cause: 18:1962 Racketeering (RICO) Act

Track this case

Case Number:

2:23-md-03080

Court:

New Jersey

Nature of Suit:

470 Racketeer/Corrupt Organization

Multi Party Litigation:

Multi-district Litigation

Judge:

Judge Brian R. Martinotti

Firms

Companies

Government Agencies

Sectors & Industries:

September 25, 2025
Conn. Cities' Insulin Pricing Suits Against PBMs Join NJ MDL

Two Connecticut cities' civil racketeering and state trade practices law claims against insulin manufacturers Eli Lilly and Co., Novo Nordisk Inc. and Sanofi-Aventis US LLC, and pharmacy benefit managers CVS Caremark, Express Scripts and Optum Rx, have been rolled into a New Jersey multidistrict litigation proceeding.
August 21, 2025
CVS, Drugmakers Illegally Inflated Insulin Prices, City Claims

Drugmakers Eli Lilly and Co., Novo Nordisk Inc. and Sanofi-Aventis US LLC, pharmacy benefit managers CVS Caremark, Express Scripts and Optum Rx, and others have been hit with civil racketeering and state unfair trade practices law claims by the city of Torrington, Connecticut, over an alleged scheme to inflate insulin prices.
June 04, 2025
Calif. Won't Get Insulin Pricing Case Sent Back To State Court

The New Jersey federal judge overseeing multidistrict litigation accusing Express Scripts, CVS Caremark and other pharmacy benefit managers of conspiring to fix the prices of insulin on Wednesday refused to ship a case brought by the state of California back to state court.
January 02, 2025
1st Private Co. Joins Insulin Price-Fixing MDL

A Florida-based car dealer is the first private company to join a multidistrict litigation accusing Novo Nordisk, Eli Lilly and Sanofi-Aventis of fixing the prices of insulin and other drugs to treat diabetes.
June 10, 2024
Drugmakers Look To Nix Non-Insulin Claims From AG Suit

Novo Nordisk, Eli Lilly and Sanofi-Aventis asked the federal judge overseeing a diabetes drug price-fixing multidistrict litigation to rule for drugmakers on Mississippi's claims the pricing for GLP-1s is illegal, saying in a brief that the drugs are under patent and too new to be included in the insulin-pricing suit.
February 08, 2024
Mich. Counties Sue Drug Giants Over Insulin Prices

Several Michigan counties on Wednesday accused some of the world's largest drugmakers, retailers and pharmacy benefit managers of scheming to inflate insulin prices and costing the municipalities millions of extra dollars in healthcare costs for their employees and retirees.
December 06, 2023
Judge Orders 3 Case Tracks, Appoints Counsel In Insulin MDL

A New Jersey federal judge on Wednesday established three tracks for cases to follow in the multidistrict litigation that accuses drugmakers and pharmacy benefit managers of illegally inflating the price of insulin.
November 29, 2023
Drug Giants Face 3rd RICO Suit In 3 Weeks Over Insulin Prices

A Maryland county south of Washington, D.C., has joined the flood of litigation accusing drugmakers and pharmacy benefit managers of violating a federal racketeering law in a scheme to jack up insulin prices.
November 21, 2023
Drug Giants Face New Racketeering Suit Over Insulin Prices

A second Virginia county in two weeks has sued Eli Lilly and others under a federal racketeering law, alleging drugmakers and pharmacy benefit managers illegally schemed to limit competition and artificially inflate the price of insulin drugs.